Dr. Kaczmar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
- SC State Medical License 2016 - 2025
- MO State Medical License 2016 - 2018
- PA State Medical License 2010 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsPhase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20 - 10 citationsNegative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.Glenn J Hanna, Scott A Roof, Jamie Jabalee, Eleni M Rettig, Rocco Ferrandino
Clinical Cancer Research. 2023-10-13 - 7 citationsRandomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.Julie E Bauman, Nabil F Saba, Denise Roe, Jessica R Bauman, John Kaczmar
Journal of Clinical Oncology. 2023-08-01
Press Mentions
- Studies Show How to Boost Immunotherapy Effectiveness for Patients with Oral-Cavity Squamous Cell CarcinomaNovember 5th, 2021
- Clinical Trial Gets Oral Cancer Survivor Through 'Mean' CancerDecember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: